Related Experiment Video
Updated: Aug 9, 2026
The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
Published on: October 3, 2012
Parkinson's disease: biology and aetiology
1Department of Medicine, University of the Witwatersrand Medical School and Johannesburg Hospital, Republic of South Africa.
Abstract:
The cause of dopamine cell death, thought to be the primary neurocytologic defect in idiopathic Parkinson's disease, remains unknown. Mitochondrial oxidative dysfunction causes premature cell death, and may be linked to accelerated apoptosis, excessive free and toxic radicals, deficient neurotrophic factors or combinations of these detrimental factors. Neurochemical imbalances result both in the substantia nigra and neostriatum, resulting in compensatory mechanisms that make this chronic neurodegenerative disease difficult to evaluate. Acute parkinsonism models have limitations when compared with chronic disease states, and caution should be present when comparing 'parkinsonism' data with human disease. Better understanding of classical neurotransmitters, neuroactive peptides and neurotrophic factors, will hopefully lead to more rational treatment approaches, cellular support strategies, and an understanding of the causes of this disease. Glial derived neurotrophic factor looks the most promising neurotrophic candidate so far tested in culture and in vivo. The result of clinical trials utilizing neurotrophic factors, both as mesencephalic implant support strategies and as definitive treatment of idiopathic Parkinson's disease, are awaited with cautious optimism.
Insights
The exact cause of dopamine cell death in Parkinson's disease is unknown, but mitochondrial dysfunction and neurotrophic factors are key areas of research. Glial derived neurotrophic factor shows promise for future Parkinson's disease treatments.
Area of Science:
- Neuroscience
- Cell Biology
- Neurology
Background:
- Idiopathic Parkinson's disease (PD) is characterized by dopamine cell death, but the underlying cause remains elusive.
- Mitochondrial oxidative dysfunction is a potential contributor, possibly involving apoptosis, free radicals, and deficient neurotrophic factors.
- Neurochemical imbalances in the substantia nigra and neostriatum complicate PD evaluation and treatment.
Purpose of the Study:
- To explore the unknown causes of dopamine cell death in idiopathic Parkinson's disease.
- To investigate the role of mitochondrial dysfunction and neurotrophic factors in PD pathogenesis.
- To identify potential therapeutic targets for Parkinson's disease.
Main Methods:
- Review of existing literature on PD neurobiology, mitochondrial function, and neurotrophic factors.
- Analysis of neurochemical imbalances and their impact on disease evaluation.
- Consideration of limitations in acute parkinsonism models versus chronic disease states.
Main Results:
- Mitochondrial oxidative dysfunction is implicated in premature cell death, potentially through apoptosis and free radical damage.
- Deficient neurotrophic factors are considered a significant factor in PD.
- Glial derived neurotrophic factor (GDNF) has emerged as a promising candidate for therapeutic intervention.
Conclusions:
- A deeper understanding of neurotransmitters, neuroactive peptides, and neurotrophic factors is crucial for developing rational treatments for PD.
- Cellular support strategies, particularly those involving neurotrophic factors like GDNF, offer potential for managing PD.
- Clinical trials investigating neurotrophic factors for PD are anticipated with cautious optimism.
Related Concept Videos
01:37Neural Regulation
01:15Parkinson's Disease: Overview
01:24Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:29Alzheimer Disease l: Introduction
01:24Parkinson Disease l: Introduction
01:24Parkinson Disease ll: Pathophysiology